Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00291525Not ApplicableCompleted

Randomized On-X Anticoagulation Trial

Role: lead

NCT02677974Active Not Recruiting

On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study

Role: lead

NCT01812174Not ApplicableTerminated

On-X Heart Valve - 17mm Aortic and 23mm Mitral

Role: lead

NCT00639782Not ApplicableCompleted

Prospective Randomized On-X Versus SJM Evaluation Trial

Role: lead

All 4 trials loaded